Does your dog turn into a shivering mess during thunderstorms or have a meltdown every time you grab your car keys? Is every ...

Madrigal Pharmaceuticals MDGL shares soared 10.9% on Wednesday. The uptrend was observed after the U.S. Patent and Trademark ...

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

The deadline for the start of Trump's heaviest tariffs has been delayed a few weeks, but a new report has nonetheless shown ...

DALLAS, TX, USA I July 14, 2025 I Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic ...

Wheatgrass flavonoids can powerfully combat oxidative stress and extend fruit fly lifespans. Scientists studying 228 ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and reduced toxicity compared with ...

Risankizumab Dose Intensification Recaptures Clinical Response in CD – An effective and safe way to manage patients after standard dosing falls short ...

QC Kinetix, a leader in regenerative medicine, is enhancing non-surgical pain relief by implementing 10 billion platelet dosing for PRP treatments.

The company announced the launch of the TUSCANY trial and the initiation of dosing in the first cohort of newly diagnosed patients with AML in January 2025. The initial dose of TUS at 40 milligrams ...